Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Differin 0.1% cream
1306010H0BBABAB
|
Differin | Adapalene | Skin | 2,255 |
|
Sunsense daily face cream SPF 50+
130801000BBNTA0
|
Proprietary compound preparation BNF 1308010 | Other sunscreening preparations | Skin | 2,245 |
|
Sunsense ultra lotion SPF 50+
130801000BBLIA0
|
Proprietary compound preparation BNF 1308010 | Other sunscreening preparations | Skin | 2,239 |
|
Sulfadiazine silver 1% cream
1310011Y0AAAAAA
|
Silver sulfadiazine | Silver sulfadiazine | Skin | 2,232 |
|
Audavate 0.1% cream
1304000F0BGADAA
|
Audavate | Betamethasone valerate | Skin | 2,224 |
|
Anhydrol Forte 20% solution
1312000C0BBAAAS
|
Anhydrol Forte | Aluminium chloride | Skin | 2,210 |
|
Dermacool 5% cream
1303000AABCADAF
|
Dermacool | Menthol | Skin | 2,208 |
|
Dermalo bath emollient
1302011M0BIAAAG
|
Dermalo | Liquid paraffin | Skin | 2,201 |
|
Potassium permanganate 400mg tablets for cutaneous solution
1311060Q0AAACAC
|
Potassium permanganate | Potassium permanganate | Skin | 2,136 |
|
Menthoderm 1% cream
1303000AABFABAB
|
Menthoderm | Menthol | Skin | 2,134 |
|
White soft paraffin 15% / Liquid paraffin light 6% cream
130201000AACDCD
|
Generic compound emollients | Other emollient preparations | Skin | 2,110 |
|
Tirbanibulin 10mg/g ointment 250mg sachets
1308010AAAAAAAA
|
Tirbanibulin | Tirbanibulin | Skin | 2,082 |
|
Eucerin Intensive 10% lotion
1302010U0BGACAM
|
Eucerin | Urea | Skin | 2,073 |
|
Betamethasone valerate 0.1% / Clioquinol 3% ointment
1304000F0AACDCD
|
Betamethasone valerate (Topical) | Betamethasone valerate | Skin | 1,977 |
|
Aluminium chloride 20% spray
1312000C0AAAWAW
|
Aluminium chloride | Aluminium chloride | Skin | 1,958 |
|
Minoxidil 5% foam
1309000H0AAALAL
|
Minoxidil (Scalp) | Minoxidil | Skin | 1,947 |
|
Betamethasone valerate 0.1% lotion
1304000F0AABCBC
|
Betamethasone valerate (Topical) | Betamethasone valerate | Skin | 1,940 |
|
Dermacolor fixing powder
130802000BBASA0
|
Proprietary compound preparation BNF 1308020 | Other camouflage preparations | Skin | 1,905 |
|
Synalar 0.025% cream
1304000N0BBAAAB
|
Synalar | Fluocinolone acetonide | Skin | 1,872 |
|
Menthol 5% in Aqueous cream
1303000AAAAAFAF
|
Menthol (Topical) | Menthol | Skin | 1,847 |
|
Anthelios sunscreen lotion SPF 50+
130801000BBPYA0
|
Proprietary compound preparation BNF 1308010 | Other sunscreening preparations | Skin | 1,804 |
|
Eucerin Intensive 10% cream
1302010U0BGADAF
|
Eucerin | Urea | Skin | 1,789 |
|
Liquid paraffin light 70% gel
1302011L0AAAHAH
|
Light liquid paraffin | Light liquid paraffin | Skin | 1,787 |
|
Coal tar extract 5% shampoo
1309000C0AAATAT
|
Coal tar (Scalp) | Coal tar | Skin | 1,773 |
|
Betamethasone 0.1% foam
1304000F0AABFBF
|
Betamethasone valerate (Topical) | Betamethasone valerate | Skin | 1,770 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.